Professional Documents
Culture Documents
Coffee Consumption Increases The Antioxidant Capacity of Plasm - 2016 - The Jour
Coffee Consumption Increases The Antioxidant Capacity of Plasm - 2016 - The Jour
Abstract
Background: Coffee, a source of antioxidants, has controversial effects on cardiovascular health.
Objective: We evaluated the bioavailability of chlorogenic acids (CGAs) in 2 coffees and the effects of their consumption
on the plasma antioxidant capacity (AC), the serum lipid profile, and the vascular function in healthy adults.
Methods: Thirty-eight men and 37 women with a mean 6 SD age of 38.5 6 9 y and body mass index of 24.1 6 2.6 kg/m2
were randomly assigned to 3 groups: a control group that did not consume coffee or a placebo and 2 groups that consumed
400 mL coffee/d for 8 wk containing a medium (MCCGA; 420 mg) or high (HCCGA; 780 mg) CGA content. Both were low in
diterpenes (0.83 mg/d) and caffeine (193 mg/d). Plasma caffeic and ferulic acid concentrations were measured by GC, and the
plasma AC was evaluated with use of the ferric-reducing antioxidant power method. The serum lipid profile, nitric oxide (NO)
plasma metabolites, vascular endothelial function (flow-mediated dilation; FMD), and blood pressure (BP) were evaluated.
Results: After coffee consumption (1 h and 8 wk), caffeic and ferulic acid concentrations increased in the coffee-drinking
groups, although the values of the 2 groups were significantly different (P < 0.001); caffeic and ferulic acid concentrations
were undetectable in the control group. At 1 h after consumption, the plasma AC in the control group was significantly
lower than the baseline value (22%) and significantly increased in the MCCGA (6%) and HCCGA (5%) groups (P < 0.05).
After 8 wk, no significant differences in the lipid, FMD, BP, or NO plasma metabolite values were observed between the groups.
Conclusions: Both coffees, which contained CGAs and were low in diterpenes and caffeine, provided bioavailable CGAs
and had a positive acute effect on the plasma AC in healthy adults and no effect on blood lipids or vascular function. The
group that did not drink coffee showed no improvement in serum lipid profile, FMD, BP, or NO plasma metabolites. This
trial was registered at registroclinico.sld.cu as RPCEC00000168. J Nutr 2016;146:524–31.
Keywords: cardiovascular disease, chlorogenic acids, phenolic acids, oxidative stress, diterpenes, caffeine,
flow-mediated dilation, cholesterol
Introduction
acids (CGAs)9 are the most prevalent (1). These compounds may
Coffee has been recognized as a natural source of antioxidants play a key role in inhibiting LDL cholesterol lipid peroxidation
because of its phenolic compound content, of which chlorogenic and in modulating oxidative stress, thereby lowering the risk of
1 atherosclerosis (2). After CGAs are acutely consumed, they
Supported by Vidarium, Nutrition, Health and Wellness Research Center, Nutresa
Business Group; CES University; and the University of Antioquia. This is a free appear not to be absorbed as such. Instead, CGAs have been
access article, distributed under terms (http://www.nutrition.org/publications/ shown to be hydrolyzed in the gastrointestinal tract, which
guidelines-and-policies/license/) that permit unrestricted noncommercial use, distri- results in the generation of end products such as caffeic and
bution, and reproduction in any medium, provided the original work is properly cited.
2
Author disclosures: GM Agudelo-Ochoa, IC Pulgarı́n-Zapata, OJ Lara-Guzmán,
9
and K Muñoz-Durango are researchers at Vidarium, Nutrition, Health and Wellness Abbreviations used: AC, antioxidant capacity; BP, blood pressure; CGA,
Research Center, Nutresa Business Group. M Naranjo-Cano and M Quintero-Ortiz chlorogenic acid; CVD, cardiovascular disease; FMD, flow-mediated dilation;
are researchers at the Colcafé Research Coffee Group, Colcafé S.A.S. CM FRAP, ferric-reducing antioxidant power; HCCGA, high chlorogenic acid content;
Velásquez-Rodrı́guez and M Duque-Ramı́rez, no conflicts of interest. LOD, limit of detection; MCCGA, medium chlorogenic acid content; TC, total
*To whom correspondence should be addressed. E-mail: gloria.agudelo@udea.edu.co. cholesterol.
TABLE 1 Characteristics of the healthy adults assigned to the three study groups1
Gender 0.91
Men 13 (52) 12 (48) 12 (50) 37
Women 12 (48) 13 (52) 12 (50) 37
Age, y 0.51
20–40 14 (56) 14 (56) 10 (42) 38
41–60 11 (44) 11 (44) 14 (58) 36
BMI,3 kg/m2 0.92
Normal 16 (64) 15 (60) 14 (58) 45
Overweight 9 (36) 10 (40) 10 (42) 29
Waist circumference,4 cm 0.39
Adequate 24 (96) 24 (96) 21 (88) 69
High 1 (4) 1 (4) 3 (12) 5
1
HCCGA, high chlorogenic acid content; MCCGA, medium chlorogenic acid content.
2
Chi-square test.
3
Normal BMI: 18.5–24.9; overweight: 25–29.9.
4
Appropriate waist circumference: men: #94 cm; women: #80 cm.
nitrate/nitrite colorimetric kit that is commercially available from The results of various studies over the last decade have demon-
Cayman Chemical Company. The quantification was performed strated the antioxidant effect of the CGAs provided by coffee.
from calibration curves, and values were expressed in mmol/L of However, it has been suggested that the absorption of CGAs
plasma (29). might be low because of their esterification (30). Several studies
have concluded that CGAs in coffee are bioavailable (31, 32).
Statistical analysis. The age, sex, and BMI of the study population was
Renouf et al. (24) provided healthy volunteers with a single dose
described with use of measures of central tendency and dispersion for
quantitative variables (data are expressed as the mean 6 SD), whereas
the qualitative variables were described through frequencies and TABLE 3 Plasma caffeic and ferulic acid concentrations at
percentages. A chi-square test was used to establish the comparability of baseline and at 1 h and 8 wk after the intervention in healthy
independent variables between the study groups. The normality of the adults1
continuous variables in each group was evaluated with the Shapiro-
Wilks test. To evaluate the differences in caffeic and ferulic acid Control (n = 25) MCCGA (n = 25) HCCGA (n = 24)
concentrations between the treated groups, the Mann-Whitney U test
was used. To evaluate the effect of the type of coffee consumed, a repeated- Caffeic acid, nM
measures ANOVA that took into account 2 time points (baseline and Baseline ND ND ND
8 wk) and the 3 treatments (control, MCCGA, and HCCGA) was 1h ND 50.5 6 6.9a 20.3 6 3.3b
performed; to evaluate AC, 3 time points (basal, 1 h, and 8 wk) and the 8 wk ND 14.1 6 0.8a 9.0 6 1.5b
3 treatments mentioned previously were taken into account. When an
Ferulic acid, nM
interaction was significant, TukeyÕs post hoc tests were applied. The
Baseline ND ND ND
normality assumptions of the model were checked, and transformations
were applied (log for TGs and HDL cholesterol and square root for NO) to 1h ND 201 6 18.7a 137 6 6.1b
the data for variables that were not normally distributed. Systolic 8 wk ND 44.6 6 0.6a 34.3 6 2.1b
blood pressure and diastolic blood pressure were not normally 1
Values are means 6 SDs. The 8-wk sample was obtained 21 h after the last
distributed even after transformation and were therefore analyzed by consumption. Labeled means within a row without a common letter differ significantly
using the nonparametric Kruskal-Wallis test. Significance was defined (Mann-Whitney U test; P , 0.001). HCCGA, high chlorogenic acid content; MCCGA,
as P < 0.05, and 2-tailed tests were used. The statistical analysis was medium chlorogenic acid content; ND, not detected (caffeic acid ,3 nM and ferulic
performed by using SPSS version 22 (IBM). acid ,5 nM).
P
Control (n = 25) MCCGA (n = 25) HCCGA (n = 24) Treatment Time Interaction
of 335 mg of soluble CGAs in coffee and showed the presence of plasma and prevent the oxidation of LDL (34). Natella et al. (35)
2 groups of metabolites, the maximum concentrations of which reported that in healthy volunteers, the AC was higher after the
were achieved between 1–12 h after coffee consumption. In our consumption of coffee instead of tea; however, other studies of
study, caffeic and ferulic acids were present in the groups that healthy adults have not found any effects of coffee on plasma AC
drank coffee and were not detectable in the control group, both (36). In our study, 1 h after the 2 types of coffee had been
after 1 h as well as 8 wk after the start of the intervention. These consumed, the plasma AC of the volunteers was significantly
findings are consistent with previous results. It is important to increased over the baseline value, in contrast to the plasma AC
note that at both the acute and chronic time points the 2 of the participants in the control group, which declined over the
metabolites were present at significantly higher concentrations same period. Similar results were reported by Corrêa et al. (37),
in the group assigned to drink the MCCGA coffee. Similar who found an increase in the AC in subjects who had consumed
results were found in the study conducted by Stalmach et al. 2 types of filtered coffee that were roasted to different degrees
(33), in which reduced absorption in the small intestine was and that had different CGA contents for 4 wk. An increase in
found to be associated with ingestion of the highest dose of some plasma AC provides greater protection against free radicals,
metabolites, probably because of saturation of the absorption which helps reduce key events in the development of CVD. The
sites. results of our study regarding the bioavailability of the CGAs in
Coffee is now recognized as a source of potent antioxidants, coffee and their effects on the AC in healthy adults suggest an
principally CGAs, that could help improve the redox state of acute positive effect that tends to decrease as the metabolites are
TABLE 5 Markers of serum lipid profile and vascular function in healthy adults at baseline and 8 wk
after the intervention1
P2
Control (n = 25) MCCGA (n = 25) HCCGA (n = 24) Treatment Time Interaction
Cholesterol, mg/dL
Baseline 196 6 32.7 196 6 33.4 211 6 31.0 0.26 0.02 0.69
8 wk 203 6 38.2 201 6 35.9 214 6 32.1
LDL cholesterol, mg/dL
Baseline 104 6 21.7 101 6 22.5 118 6 24.7 0.04 0.29 0.58
8 wk 107 6 26.0 103 6 23.8 118 6 23.2
HDL cholesterol, mg/dL
Baseline 50.7 6 13.9 52.9 6 12.8 50.6 6 10.3 0.84 0.16 0.26
8 wk 52.4 6 12.5 53.2 6 13.5 51.0 6 10.9
TGs, mg/dL
Baseline 114 6 53.6 118 6 56.0 121 6 51.7 0.74 0.09 0.37
8 wk 125 6 101.8 134 6 65.1 122 6 51.2
Arterial index
Baseline 4.1 6 1.0 3.9 6 0.9 4.3 6 0.9 0.33 0.42 0.53
8 wk 4.0 6 1.1 4.0 6 1.1 4.3 6 0.9
FMD, %
Baseline 13.2 6 11.1 13.6 6 12.3 21.3 6 11.0 0.26 0.13 0.50
8 wk 18.4 6 18.1 19.5 6 18.1 21.1 6 21.2
NO metabolites, μmol/L
Baseline 3.0 6 1.3 3.3 6 1.0 3.0 6 1.1 0.20 0.49 0.27
8 wk 2.7 6 1.7 4.0 6 3.6 4.3 6 3.5
1
Values are means 6 SDs. FMD, flow-mediated dilation; HCCGA, high chlorogenic acid content; MCCGA, medium chlorogenic acid
content.
2
Repeated-measures ANOVA.